{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:24:41Z","timestamp":1786119881598,"version":"build-2736575974"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1097\/hjh.0b013e328347da0f","type":"journal-article","created":{"date-parts":[[2011,5,20]],"date-time":"2011-05-20T05:30:57Z","timestamp":1305869457000},"page":"1337-1346","source":"Crossref","is-referenced-by-count":9,"title":["Olmesartan ameliorates peripheral nerve dysfunction in Zucker diabetic fatty rats"],"prefix":"10.1097","volume":"29","author":[{"given":"Kazuhiro","family":"Sugimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiya","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Yasujima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210208","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"R2-15-20210208","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"R3-15-20210208","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(08)61411-7","article-title":"Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial","volume":"372","author":"Sjolie","year":"2008","journal-title":"Lancet"},{"key":"R4-15-20210208","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/S0140-6736(98)02478-7","article-title":"Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial","volume":"352","author":"Malik","year":"1998","journal-title":"Lancet"},{"key":"R5-15-20210208","first-page":"E530","article-title":"Nerve function and regeneration in diabetic rats: effects of ZD-7155, an AT1 receptor antagonist","volume":"269","author":"Maxfield","year":"1995","journal-title":"Am J Physiol"},{"key":"R6-15-20210208","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2337\/diabetes.55.02.06.db05-0885","article-title":"ACE inhibitor or angiotensin II receptor antagonist attenuates diabetic neuropathy in streptozotocin-induced diabetic rats","volume":"55","author":"Coppey","year":"2006","journal-title":"Diabetes"},{"key":"R7-15-20210208","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1463-1326.2007.00814.x","article-title":"Vascular and neural dysfunction in Zucker diabetic fatty rats: a difficult condition to reverse","volume":"10","author":"Oltman","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"R8-15-20210208","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2165\/00129784-200505040-00004","article-title":"Neuroprotection with angiotensin receptor antagonists: a review of the evidence and potential mechanisms","volume":"5","author":"Wilms","year":"2005","journal-title":"Am J Cardiovasc Drugs"},{"key":"R9-15-20210208","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/01.HYP.35.1.155","article-title":"Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function","volume":"35","author":"Carey","year":"2000","journal-title":"Hypertension"},{"key":"R10-15-20210208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1470320309347793","article-title":"The angiotensin II type 2 receptor in the brain","volume":"11","author":"Horiuchi","year":"2010","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"R11-15-20210208","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1097\/01.hjh.0000239297.63377.3f","article-title":"Irbesartan restores the in-vivo insulin signaling pathway leading to Akt activation in obese Zucker rats","volume":"24","author":"Munoz","year":"2006","journal-title":"J Hypertens"},{"key":"R12-15-20210208","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1097\/HJH.0b013e328304b060","article-title":"Angiotensin receptor blockers improve insulin signaling and prevent microvascular rarefaction in the skeletal muscle of spontaneously hypertensive rats","volume":"26","author":"Rizzoni","year":"2008","journal-title":"J Hypertens"},{"key":"R13-15-20210208","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1097\/00004872-200410000-00021","article-title":"Blockade of the renin-angiotensin system decreases adipocyte size with improvement in insulin sensitivity","volume":"22","author":"Furuhashi","year":"2004","journal-title":"J Hypertens"},{"key":"R14-15-20210208","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1161\/01.HYP.0000125142.41703.64","article-title":"Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice","volume":"43","author":"Shiuchi","year":"2004","journal-title":"Hypertension"},{"key":"R15-15-20210208","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00004872-200502000-00021","article-title":"Effect of insulin and angiotensin II receptor subtype-1 antagonist on myocardial remodelling in rats with insulin-dependent diabetes mellitus","volume":"23","author":"Al Jaroudi","year":"2005","journal-title":"J Hypertens"},{"key":"R16-15-20210208","doi-asserted-by":"crossref","first-page":"934","DOI":"10.2337\/db08-1287","article-title":"Intranasal insulin ameliorates experimental diabetic neuropathy","volume":"58","author":"Francis","year":"2009","journal-title":"Diabetes"},{"key":"R17-15-20210208","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1291\/hypres.25.271","article-title":"Renoprotective effects of blockade of angiotensin II AT1 receptors in an animal model of type 2 diabetes","volume":"25","author":"Mizuno","year":"2002","journal-title":"Hypertens Res"},{"key":"R18-15-20210208","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/dmrr.903","article-title":"Time course of pain sensation in rat models of insulin resistance, type 2 diabetes, and exogenous hyperinsulinaemia","volume":"24","author":"Sugimoto","year":"2008","journal-title":"Diabetes Metab Res Rev"},{"key":"R19-15-20210208","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/mus.20474","article-title":"Prolonged ischemic conduction failure after reperfusion in diabetic nerve","volume":"33","author":"Baba","year":"2006","journal-title":"Muscle Nerve"},{"key":"R20-15-20210208","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00401-004-0915-2","article-title":"Peripheral nerve endoneurial microangiopathy and necrosis in rats with insulinoma","volume":"108","author":"Sugimoto","year":"2004","journal-title":"Acta Neuropathol (Berl)"},{"key":"R21-15-20210208","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1212\/WNL.47.4.1042","article-title":"Quantitation of epidermal nerves in diabetic neuropathy","volume":"47","author":"Kennedy","year":"1996","journal-title":"Neurology"},{"key":"R22-15-20210208","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jpain.2007.10.016","article-title":"Early changes in insulin receptor signaling and pain sensation in streptozotocin-induced diabetic neuropathy in rats","volume":"9","author":"Sugimoto","year":"2008","journal-title":"J Pain"},{"key":"R23-15-20210208","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1212\/WNL.48.3.708","article-title":"Intraepidermal nerve fiber density in patients with painful sensory neuropathy","volume":"48","author":"Holland","year":"1997","journal-title":"Neurology"},{"key":"R24-15-20210208","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1097\/WNR.0b013e32833283e6","article-title":"Olmesartan medoxomil ameliorates sciatic nerve regeneration in diabetic rats","volume":"20","author":"Nakamura","year":"2009","journal-title":"Neuroreport"},{"key":"R25-15-20210208","doi-asserted-by":"crossref","first-page":"E113","DOI":"10.1152\/ajpendo.00594.2004","article-title":"Progression of vascular and neural dysfunction in sciatic nerves of Zucker diabetic fatty and Zucker rats","volume":"289","author":"Oltman","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R26-15-20210208","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1212\/01.WNL.0000058546.16985.11","article-title":"Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology","volume":"60","author":"Shy","year":"2003","journal-title":"Neurology"},{"key":"R27-15-20210208","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.2337\/dc06-0650","article-title":"Early involvement of the spinal cord in diabetic peripheral neuropathy","volume":"29","author":"Selvarajah","year":"2006","journal-title":"Diabetes Care"},{"key":"R28-15-20210208","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1096\/fj.04-2960fje","article-title":"Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury","volume":"19","author":"Li","year":"2005","journal-title":"FASEB J"},{"key":"R29-15-20210208","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.1167\/iovs.06-0478","article-title":"Neuroprotective effects of angiotensin II type 1 receptor (AT1R) blocker, telmisartan, via modulating AT1R and AT2R signaling in retinal inflammation","volume":"47","author":"Kurihara","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R30-15-20210208","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.devbrainres.2004.02.007","article-title":"Development of AT(1) and AT(2) receptors in the ovine fetal brain","volume":"150","author":"Hu","year":"2004","journal-title":"Brain Res Dev Brain Res"},{"key":"R31-15-20210208","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.brainres.2008.09.099","article-title":"Expression and transport of angiotensin II AT1 receptors in spinal cord, dorsal root ganglia and sciatic nerve of the rat","volume":"1246","author":"Pavel","year":"2008","journal-title":"Brain Res"},{"key":"R32-15-20210208","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/jnr.490420414","article-title":"Regulation of protease nexin-1 and angiotensin II receptor subtype 1 expression: inverse relationship in experimental models of nerve injury","volume":"42","author":"Bleuel","year":"1995","journal-title":"J Neurosci Res"},{"key":"R33-15-20210208","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1007\/s00125-006-0379-0","article-title":"Degeneration of the Golgi and neuronal loss in dorsal root ganglia in diabetic BioBreeding\/Worcester rats","volume":"49","author":"Kamiya","year":"2006","journal-title":"Diabetologia"},{"key":"R34-15-20210208","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1096\/fj.02-1193fje","article-title":"Angiotensin II accelerates functional recovery in the rat sciatic nerve in vivo: role of the AT2 receptor and the transcription factor NF-kappaB","volume":"17","author":"Reinecke","year":"2003","journal-title":"FASEB J"},{"key":"R35-15-20210208","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1172\/JCI5971","article-title":"Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa\/fa) rats","volume":"104","author":"Jiang","year":"1999","journal-title":"J Clin Invest"},{"key":"R36-15-20210208","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s001250051439","article-title":"Mitogen-activated protein kinases as glucose transducers for diabetic complications","volume":"42","author":"Tomlinson","year":"1999","journal-title":"Diabetologia"},{"key":"R37-15-20210208","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1172\/JCI119752","article-title":"Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin\/angiotensin II crosstalk","volume":"100","author":"Folli","year":"1997","journal-title":"J Clin Invest"},{"key":"R38-15-20210208","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/dmrr.611","article-title":"The multifaceted cross-talk between the insulin and angiotensin II signaling systems","volume":"22","author":"Velloso","year":"2006","journal-title":"Diabetes Metab Res Rev"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/HJH.0b013e328347da0f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:24:55Z","timestamp":1786044295000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004872-201107000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/hjh.0b013e328347da0f","relation":{},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}